The initial assessment of expert panel performance in core hospitals for cancer genomic medicine in Japan

BACKGROUND: Since June 2019, cancer genomic profiling (CGP) tests have been reimbursed by the National Health Insurance system in Japan, with restrictions for government-designated hospitals with a molecular tumor board composed of multidisciplinary specialists, known as an expert panel (EP). The st...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Clin Oncol
Main Authors: Sunami, Kuniko, Naito, Yoichi, Aimono, Eriko, Amano, Toraji, Ennishi, Daisuke, Kage, Hidenori, Kanai, Masashi, Komine, Keigo, Koyama, Takafumi, Maeda, Takahiro, Morita, Sachi, Sakai, Daisuke, Kohsaka, Shinji, Tsuchihara, Katsuya, Yoshino, Takayuki
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Singapore 2021
Assuntos:
Special Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7895780/
https://ncbi.nlm.nih.gov/pubmed/33385275
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10147-020-01844-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados